SC
Smith Christopher M
Chairman & CEO
C-suiteM
Insider track record
CEOAcross 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Smith Christopher M, Chairman & CEO. Officer active across 4 companies, notably Ortho Clinical Diagnostics Holdings plc. In total, 15 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €3.8m. History available since 2 August 2021. The latest transaction was disclosed on 23 February 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations15 total
57,413 shares0Common StockSEC:0001077183-25-000039:0
54,099 shares0Common StockSEC:0001299130-25-000022:0
48,063 shares0Common StockSEC:0001077183-24-000168:0
33,130 shares0Common StockSEC:0001077183-24-000143:0
48,063 shares0Common StockSEC:0001077183-24-000075:0
2,248 shares0Common StockSEC:0001209191-23-035401:0
1,225 shares@ US$85.54100.0% of flowCommon StockSEC:0001209191-23-033101:0
336,767 shares0Common StockSEC:0001077183-22-000148:0
34,554 sharesCommon StockSEC:0001209191-22-043762:0
34,554 sharesCommon StockSEC:0000899243-22-020478:0
367,360 sharesOrdinary Shares, $0.00001 par valueSEC:0000899243-22-020381:0
100,000 shares@ US$12.5618.3% of flowOrdinary Shares, $0.00001 par valueSEC:0001209191-22-001678
100,000 shares@ US$12.5618.3% of flowOrdinary Shares, $0.00001 par valueSEC:0001209191-22-001678:0
103,213 shares@ US$22.100331.7% of flowOrdinary Shares, $0.00001 par valueSEC:0001209191-21-049757:0
103,213 shares@ US$22.100331.7% of flowOrdinary Shares, $0.00001 par valueSEC:0001209191-21-049757
About Smith Christopher M
Christopher M. Smith is the Chairman and CEO and Board Member of Ortho Clinical Diagnostics Holdings plc and QuidelOrtho Corp. He leads these companies with a strategic vision focused on innovation and improving healthcare. Under his leadership, Ortho Clinical Diagnostics and QuidelOrtho are committed to providing quality diagnostic solutions. Christopher M. Smith is recognized for his expertise in the diagnostics sector.